HEADER HYDROLASE/HYDROLASE INHIBITOR 18-APR-07 2PKS TITLE THROMBIN IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: THROMBIN LIGHT CHAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 335-361; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: THROMBIN HEAVY CHAIN FRAGMENT; COMPND 7 CHAIN: B; COMPND 8 FRAGMENT: RESIDUES 364-510; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: THROMBIN HEAVY CHAIN FRAGMENT; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: RESIDUES 518-619; COMPND 13 MOL_ID: 4; COMPND 14 MOLECULE: HIRUDIN; COMPND 15 CHAIN: D; COMPND 16 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 MOL_ID: 2; SOURCE 5 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 6 ORGANISM_COMMON: HUMAN; SOURCE 7 MOL_ID: 3; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 MOL_ID: 4; SOURCE 11 SYNTHETIC: YES; SOURCE 12 OTHER_DETAILS: CHEMICALLY SYNTHESIZED. KEYWDS INHIBITOR COMPLEX, THROMBIN INHIBITOR, HYDROLASE, HYDROLASE-HYDROLASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.XUE REVDAT 4 18-OCT-17 2PKS 1 REMARK REVDAT 3 13-JUL-11 2PKS 1 VERSN REVDAT 2 24-FEB-09 2PKS 1 VERSN REVDAT 1 22-APR-08 2PKS 0 JRNL AUTH D.BLOMBERG,T.FEX,Y.XUE,K.BRICKMANN,J.KIHLBERG JRNL TITL DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF THROMBIN JRNL TITL 2 INHIBITORS BASED ON A PYRIDINE SCAFFOLD. JRNL REF ORG.BIOMOL.CHEM. V. 5 2599 2007 JRNL REFN ISSN 1477-0520 JRNL PMID 18019535 JRNL DOI 10.1039/B705344D REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 69.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 87.7 REMARK 3 NUMBER OF REFLECTIONS : 10553 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.259 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 502 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 707 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.2450 REMARK 3 BIN FREE R VALUE SET COUNT : 33 REMARK 3 BIN FREE R VALUE : 0.3350 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2327 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 47 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.91 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.20000 REMARK 3 B22 (A**2) : -2.35000 REMARK 3 B33 (A**2) : 1.19000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.72000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.135 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.336 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.220 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.701 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.897 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2414 ; 0.019 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3262 ; 1.915 ; 1.985 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 282 ; 7.528 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 113 ;37.127 ;23.451 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 426 ;19.153 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 20 ;16.851 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 334 ; 0.125 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1844 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1103 ; 0.250 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1559 ; 0.315 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 133 ; 0.176 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 29 ; 0.244 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1422 ; 1.017 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2294 ; 1.894 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1046 ; 2.528 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 968 ; 4.046 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2PKS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAY-07. REMARK 100 THE DEPOSITION ID IS D_1000042485. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL; NULL REMARK 200 TEMPERATURE (KELVIN) : 100; NULL REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N; NULL REMARK 200 RADIATION SOURCE : ROTATING ANODE; NULL REMARK 200 BEAMLINE : NULL; NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418; NULL REMARK 200 MONOCHROMATOR : MIRRORS; NULL REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; NULL REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH; NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 10962 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 69.673 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 91.1 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : 0.08600 REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.57 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.52600 REMARK 200 R SYM FOR SHELL (I) : 0.42300 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 27% PEG8000, 0.1M SODIUM PHOSPHATE, PH REMARK 280 7.3, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 34.97100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 35.92150 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 34.97100 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 35.92150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE MONOMER PRESENT IN THE ASYMMETRIC UNIT IS THE REMARK 300 BIOLOGICAL UNIT REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 15 -86.18 -119.62 REMARK 500 SER B 48 56.85 -146.26 REMARK 500 SER B 58 -89.83 -42.25 REMARK 500 GLN B 60 109.38 -27.80 REMARK 500 LEU B 81 -62.63 -91.60 REMARK 500 ASN B 89 79.56 -159.41 REMARK 500 HIS B 102 -52.61 -120.05 REMARK 500 ASN B 110 -16.29 71.78 REMARK 500 ARG B 125 32.54 -89.74 REMARK 500 GLU B 130 -72.45 -121.78 REMARK 500 ASN C 214 31.19 -91.48 REMARK 500 GLU C 224 -40.56 -21.49 REMARK 500 ARG C 227 -158.85 -96.35 REMARK 500 SER C 235 143.84 -36.67 REMARK 500 SER C 256 -74.11 -122.35 REMARK 500 GLU D 357 122.79 -31.41 REMARK 500 GLU D 358 137.21 -38.19 REMARK 500 PRO D 360 141.73 -29.17 REMARK 500 TYS D 363 24.62 -79.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE NA C 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE G44 C 101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN D OF HIRUDIN DBREF 2PKS A 7 33 UNP P00734 THRB_HUMAN 334 360 DBREF 2PKS B 37 183 UNP P00734 THRB_HUMAN 364 510 DBREF 2PKS C 185 286 UNP P00734 THRB_HUMAN 518 619 DBREF 2PKS D 355 364 UNP P28504 HIR2_HIRME 55 64 SEQADV 2PKS GLY D 361 UNP P28504 GLU 61 CONFLICT SEQRES 1 A 27 ALA ASP CYS GLY LEU ARG PRO LEU PHE GLU LYS LYS SER SEQRES 2 A 27 LEU GLU ASP LYS THR GLU ARG GLU LEU LEU GLU SER TYR SEQRES 3 A 27 ILE SEQRES 1 B 147 ILE VAL GLU GLY SER ASP ALA GLU ILE GLY MET SER PRO SEQRES 2 B 147 TRP GLN VAL MET LEU PHE ARG LYS SER PRO GLN GLU LEU SEQRES 3 B 147 LEU CYS GLY ALA SER LEU ILE SER ASP ARG TRP VAL LEU SEQRES 4 B 147 THR ALA ALA HIS CYS LEU LEU TYR PRO PRO TRP ASP LYS SEQRES 5 B 147 ASN PHE THR GLU ASN ASP LEU LEU VAL ARG ILE GLY LYS SEQRES 6 B 147 HIS SER ARG THR ARG TYR GLU ARG ASN ILE GLU LYS ILE SEQRES 7 B 147 SER MET LEU GLU LYS ILE TYR ILE HIS PRO ARG TYR ASN SEQRES 8 B 147 TRP ARG GLU ASN LEU ASP ARG ASP ILE ALA LEU MET LYS SEQRES 9 B 147 LEU LYS LYS PRO VAL ALA PHE SER ASP TYR ILE HIS PRO SEQRES 10 B 147 VAL CYS LEU PRO ASP ARG GLU THR ALA ALA SER LEU LEU SEQRES 11 B 147 GLN ALA GLY TYR LYS GLY ARG VAL THR GLY TRP GLY ASN SEQRES 12 B 147 LEU LYS GLU THR SEQRES 1 C 102 GLY GLN PRO SER VAL LEU GLN VAL VAL ASN LEU PRO ILE SEQRES 2 C 102 VAL GLU ARG PRO VAL CYS LYS ASP SER THR ARG ILE ARG SEQRES 3 C 102 ILE THR ASP ASN MET PHE CYS ALA GLY TYR LYS PRO ASP SEQRES 4 C 102 GLU GLY LYS ARG GLY ASP ALA CYS GLU GLY ASP SER GLY SEQRES 5 C 102 GLY PRO PHE VAL MET LYS SER PRO PHE ASN ASN ARG TRP SEQRES 6 C 102 TYR GLN MET GLY ILE VAL SER TRP GLY GLU GLY CYS ASP SEQRES 7 C 102 ARG ASP GLY LYS TYR GLY PHE TYR THR HIS VAL PHE ARG SEQRES 8 C 102 LEU LYS LYS TRP ILE GLN LYS VAL ILE ASP GLN SEQRES 1 D 10 ASP PHE GLU GLU ILE PRO GLY GLU TYS LEU MODRES 2PKS TYS D 363 TYR O-SULFO-L-TYROSINE HET TYS D 363 16 HET NA C 402 1 HET G44 C 101 26 HETNAM TYS O-SULFO-L-TYROSINE HETNAM NA SODIUM ION HETNAM G44 4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL) HETNAM 2 G44 BENZENECARBOXIMIDAMIDE FORMUL 4 TYS C9 H11 N O6 S FORMUL 5 NA NA 1+ FORMUL 6 G44 C21 H20 N4 O FORMUL 7 HOH *47(H2 O) HELIX 1 1 PHE A 15 SER A 19 5 5 HELIX 2 2 THR A 24 TYR A 32 1 9 HELIX 3 3 ALA B 77 CYS B 80 5 4 HELIX 4 4 PRO B 84 ASP B 87 5 4 HELIX 5 5 THR B 91 ASN B 93 5 3 HELIX 6 6 ASP B 158 LEU B 166 1 9 HELIX 7 7 GLU C 199 ASP C 205 1 7 HELIX 8 8 LEU C 276 GLN C 286 1 11 HELIX 9 9 PRO D 360 LEU D 364 5 5 SHEET 1 A 8 SER B 41 ASP B 42 0 SHEET 2 A 8 GLN C 191 VAL C 198 -1 O VAL C 192 N SER B 41 SHEET 3 A 8 MET C 215 ALA C 218 -1 O CYS C 217 N VAL C 198 SHEET 4 A 8 GLY C 268 HIS C 272 -1 O TYR C 270 N PHE C 216 SHEET 5 A 8 TRP C 249 TRP C 257 -1 N TRP C 257 O PHE C 269 SHEET 6 A 8 PRO C 238 LYS C 242 -1 N MET C 241 O TYR C 250 SHEET 7 A 8 LYS B 171 GLY B 176 -1 N ARG B 173 O VAL C 240 SHEET 8 A 8 GLN C 191 VAL C 198 -1 O GLN C 191 N GLY B 176 SHEET 1 B 7 GLN B 51 ARG B 56 0 SHEET 2 B 7 GLU B 61 LEU B 68 -1 O LEU B 63 N LEU B 54 SHEET 3 B 7 TRP B 73 THR B 76 -1 O LEU B 75 N SER B 67 SHEET 4 B 7 ALA B 137 LEU B 141 -1 O MET B 139 N VAL B 74 SHEET 5 B 7 LYS B 113 ILE B 122 -1 N GLU B 118 O LYS B 140 SHEET 6 B 7 LEU B 95 ILE B 99 -1 N ILE B 99 O LYS B 113 SHEET 7 B 7 GLN B 51 ARG B 56 -1 N PHE B 55 O LEU B 96 SHEET 1 C 2 LEU B 82 TYR B 83 0 SHEET 2 C 2 LYS B 88 ASN B 89 -1 O LYS B 88 N TYR B 83 SSBOND 1 CYS A 9 CYS B 155 1555 1555 2.05 SSBOND 2 CYS B 64 CYS B 80 1555 1555 2.00 SSBOND 3 CYS C 203 CYS C 217 1555 1555 2.01 SSBOND 4 CYS C 231 CYS C 261 1555 1555 2.02 SITE 1 AC1 4 ARG C 263 LYS C 266 HOH C 406 HOH C 413 SITE 1 AC2 12 TRP B 86 ILE C 209 ASP C 229 ALA C 230 SITE 2 AC2 12 SER C 235 SER C 256 TRP C 257 GLY C 258 SITE 3 AC2 12 GLY C 260 GLY C 268 HOH C 405 HOH C 408 SITE 1 AC3 11 PHE B 55 GLN B 60 LEU B 96 ARG B 98 SITE 2 AC3 11 ARG B 104 THR B 105 ARG B 106 TYR B 107 SITE 3 AC3 11 GLU B 112 LYS B 113 ILE B 114 CRYST1 69.942 71.843 70.778 90.00 100.23 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014298 0.000000 0.002580 0.00000 SCALE2 0.000000 0.013919 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014357 0.00000 MASTER 284 0 3 9 17 0 7 6 0 0 0 24 END